Baronsmead Second Venture Trust plc
Half-yearly report for the six months ended 31 March
2024
The Directors of Baronsmead Second
Venture Trust plc are pleased to announce the unaudited half-yearly
financial report for the six months to 31 March 2024. Copies of the
half-yearly report can be obtained from the following
website: www.baronsmeadvcts.co.uk.
Our
investment objective
- Baronsmead Second Venture Trust plc
(the "Company") is a tax efficient listed company which aims to
achieve long-term positive investment returns for private
investors, including tax free dividends.
Investment policy1
- To invest primarily in a diverse
portfolio of UK growth businesses, whether unquoted or traded on
the Alternative Investment Market ("AIM").
- Investments are made selectively
across a range of sectors in companies that have the potential to
grow and enhance their value.
Dividend policy2
- The Board will, where possible,
seek to pay two dividends to shareholders in each financial year,
typically an interim dividend in September and a final dividend
following the Annual General Meeting in February/March.
- The Board will use, as a guide,
when setting the dividends for a financial year, a sum representing
7 per cent. of the opening net asset value of that financial
year.
1. This is a summary of the
Company's investment policy that is set out on page 99 of the
Company's Annual Report and Financial Statements for the year ended
30 September 2023.
2. This is a summary of the
Company's dividend policy that is set out on page 36 of the
Company's Annual Report and Financial Statements for the year ended
30 September 2023.
Key
elements of the business model
Access to an attractive, diverse portfolio
The Company gives shareholders
access to a diverse portfolio of growth businesses.
The Company will make investments in
growth businesses, whether unquoted or traded on AIM, which are
substantially based in the UK in accordance with the prevailing VCT
legislation. Investments are made selectively across a range of
sectors.
The
Manager's approach to investing
The Manager endeavours to select the
best opportunities and applies a distinctive selection criteria
based on:
· Primarily investing in parts of the economy which are
experiencing long-term structural growth.
· Businesses that demonstrate, or have the potential for, market
leadership in their niche.
· Management teams that can develop and deliver profitable and
sustainable growth.
· Companies with the potential to become an attractive asset
appealing to a range of buyers at the appropriate time to
sell.
In order to ensure a strong pipeline
of opportunities, the Manager invests in building deep sector
knowledge and networks and undertakes significant proactive
marketing to interesting target companies in preferred sectors.
This approach generates a network of potentially suitable
businesses with which the Manager maintains a relationship ahead of
possible investment opportunities.
The
Manager as an influential shareholder
The Manager is an engaged and
supportive shareholder (on behalf of the Company) in both unquoted
and significant quoted investments.
For unquoted investments,
representatives of the Manager often join the investee
board.
The role of the Manager with
investees is to ensure that strategy is clear, the business plan
can be implemented and that management resources are in place to
deliver profitable growth. The intention is to build on the
business model and grow the company into an attractive target which
can be sold or potentially floated in the medium term.
Financial highlights
329.7p Net Asset Value ("NAV")
total return to shareholders for every 100.0p invested at launch
(January 2001).
NAV per share increased 3.8 per cent. to 57.7p before the deduction of dividends
in the six months to 31 March 2024.
£25.0mn raised in the
period (before costs).
£7.3mn Investments made
into four new and six follow-on opportunities during the period.
(Unquoted: £6.2mn, Quoted: £1.1mn).
Cash returned to shareholders
The table below shows the cash
returned to shareholders that invested in Baronsmead Second Venture Trust plc
dependent on their subscription cost, including the income tax
available to be reclaimed on the subscription.
Year
subscribed
|
Cash invested
(p)
|
Income tax reclaim
(p)
|
Net
cash invested
(p)
|
Cumulative dividends
paid#
(p)
|
Return on cash invested# (%)
|
2001 (January)
|
100.00
|
20.00
|
80.00
|
166.55
|
186.6
|
2005 (March) - C Share*
|
100.00
|
40.00
|
60.00
|
121.12
|
161.1
|
2010 (March)
|
103.09
|
30.93
|
72.16
|
118.25
|
144.7
|
2012 (December)
|
117.40
|
35.22
|
82.18
|
100.25
|
115.4
|
2014 (March)
|
112.40
|
33.72
|
78.68
|
80.25
|
101.4
|
2016 (February)
|
107.20
|
32.16
|
75.04
|
63.75
|
89.5
|
2017 (October)
|
97.48
|
29.24
|
68.24
|
43.75
|
74.9
|
2019 (February)
|
85.30
|
25.59
|
59.71
|
36.25
|
72.5
|
2019 (November)
|
78.90
|
23.67
|
55.23
|
28.75
|
66.4
|
2020 (January)
|
84.80
|
25.44
|
59.36
|
28.75
|
63.9
|
2020 (February)
|
82.50
|
24.75
|
57.75
|
25.25
|
60.6
|
2020 (March)
|
64.30
|
19.29
|
45.01
|
25.25
|
69.3
|
2020 (November)
|
77.90
|
23.37
|
54.53
|
22.25
|
58.6
|
2020 (December)
|
80.90
|
24.27
|
56.63
|
22.25
|
57.5
|
2021 (January)
|
84.40
|
25.32
|
59.08
|
22.25
|
56.4
|
2021 (February)
|
82.20
|
24.66
|
57.54
|
18.75
|
52.8
|
2021 (March)
|
84.90
|
25.47
|
59.43
|
18.75
|
52.1
|
2021 (December)
|
88.10
|
26.43
|
61.67
|
15.75
|
47.9
|
2022 (January)
|
87.10
|
26.13
|
60.97
|
15.75
|
48.1
|
2022 (March)
|
76.60
|
22.98
|
53.62
|
12.25
|
46.0
|
2023 (January)
|
68.19†
|
20.46
|
47.73
|
9.25
|
43.6
|
2023 (March)
|
65.72†
|
19.72
|
46.00
|
6.25
|
39.5
|
2023 (April)
|
62.96†
|
18.89
|
44.07
|
6.25
|
39.9
|
2024 (January)
|
61.05†
|
18.32
|
42.74
|
4.00
|
36.6
|
2024 (February)
|
60.63†
|
18.19
|
42.44
|
1.75
|
32.9
|
2024 (April)
|
60.67†
|
18.20
|
42.47
|
1.75
|
32.9
|
The total return could be higher for those shareholders who
were able to defer a capital gain on subscription and the net sum
invested may be less.
* Dividends paid to C shareholders post conversion
have been adjusted by the conversion ratio
(0.85642528).
# Includes interim dividend of 1.75p per share payable 9
September 2024.
† Average effective offer price. Shares were allotted
pursuant to the 2023 & 2024 Offers at individual prices for
each investor in accordance with the allotment formula as set out
in each Offers Securities Note.
Chair's statement
I am pleased to announce that,
despite the volatile market conditions witnessed over the last six
months, the Company's net asset value increased by 2.1p per share
to 57.7p. As described more fully below,
the strong performance of the Company's listed portfolio outweighed
the weakness in the value of the Company's unquoted investments and
this once again highlights the benefits of
the Company's investment policy of having a combination of unquoted
and listed assets. This approach supports the Company's aim of
providing a more consistent total return to shareholders over the
medium to long term. After the period end,
the NAV has continued to increase through further good performance
of the listed portfolio, as reported on below.
Over the six months to 31 March
2024, whilst the Bank of England base rate remained at 5.25%, the
highest level in 15 years, hostilities in the Middle East
intensified global uncertainty. However, continued reductions in
headline inflation and the stable base rate supported a rebound in
UK equity performance during the latter part of 2023, with markets
pricing in expectations of continued moderating inflation and
falling interest rates in 2024. In the first months of 2024,
inflation fell by more than many economists predicted but the
benefits were felt unevenly across the UK equity market. Large cap
stocks outperformed their smaller counterparts over the period and
this was partly attributable to investors' lack of confidence in
this section of the market and the further outflows of money from
UK funds investing in smaller cap companies.
As we enter the new quarter, it's
fair to say that consumer and business confidence remain fragile
with elevated macroeconomic and geopolitical uncertainty expected
to continue to drive market volatility over the coming months.
However, your Board continues to believe that, in aggregate, the
fundamentals of the underlying portfolio companies remain robust
and the growth prospects for the majority of investee companies
continue to be positive over the medium term.
Results
During the six months to 31 March
2024, the Company's NAV per share increased 3.8 per cent. from
55.6p to 57.7p after the payment of a final dividend of 2.25p per
share on 8 March 2024. The table below breaks down the movement in
NAV over the 6 months.
|
Pence per ordinary
share
|
NAV
as at 1 October 2023 (after deducting the
final dividend of 2.25p)
|
55.6
|
Valuation increase (3.8 per
cent.)
|
2.1
|
NAV
as at 31 March 2024
|
57.7
|
The Board is pleased to report as at
31 May 2024, the NAV was 59.8p per share, a 3.6 per cent. increase
over the NAV as at 31 March 2024. This was driven by firmer quoted
markets and further increases in the value of the Company's listed
investments.
Dividends
The Board has declared an interim
dividend of 1.75p per share to be paid on 9 September 2024 to
shareholders on the register as of 9 August 2024. The Board is
aware that dividends are an important part of the total return to
the shareholders' investment in the Company. As such, the Board is
aiming to achieve its dividend policy objective of an annual yield
of 7.0 per cent. based on the NAV at the beginning of the financial
year. I must of course remind shareholders this is not a guarantee
and that payment dates and the amount of future dividends depend on
the level and timing of profitable realisations.
Portfolio review
The table below provides a summary
of each asset class and the return generated during the period
under review.
Asset class
|
NAV
(£mn)
|
% of NAV*
|
Number of investee
companies**
|
% return in the
period***
|
Unquoted
|
53
|
25
|
40
|
(4)
|
AIM- traded companies
|
83
|
38
|
42
|
8
|
WS Gresham House UK Equity
Funds
|
68
|
32
|
90
|
8
|
Liquid assets#
|
11
|
5
|
N/A
|
3
|
Total
|
215
|
100
|
172
|
4
|
*
By value at 31 March 2024.
** Includes
investee companies held in more than one fund. Total number of
individual companies held is 159.
***
Return includes interest received on unquoted realisations during
the period.
# Represents cash, cash
liquidity funds and net current assets. % return in the period
relates only to the cash liquidity funds.
The value of the unquoted portfolio
decreased 3.8 per cent. in the six months to 31 March 2024. The
drop in value was driven by the reduction in value of one key
asset, with the remaining portfolio showing an increase in value
over the period.
The value of the Company's portfolio
of investments directly held in AIM-traded companies increased 8.2
per cent. in the six months to 31 March 2024. The value of the
Company's investment into the WS Gresham House UK Micro Cap Fund
("Micro Cap") increased by 6.7 per cent., the WS Gresham House UK
Smaller Companies Fund increased by 9.2 per cent. and the WS
Gresham House UK Multi Cap Income Fund ("Multi Cap Income")
increased by 7.4 per cent. in the period. This was primarily due to
positive news flow from individual companies across the portfolio
being well received by the markets with a number of trading updates
demonstrating better than expected financial
performance.
In the Manager's regular reporting
to the Board, the Directors were pleased to learn that in the 6
months to 31 March 2024, a number of companies in our listed
portfolio reported in-line or positive news flow in terms of their
financial performance. This is welcome given the economic and
political environment which we are facing.
Investments and divestments
The Company's investments and
divestments during the period are set out below.
Investments
I am pleased to report that the
Company made four new investments totalling £4.4mn and six
follow-on investments with a combined value of £2.9mn in the six
months to 31 March 2024. Below are descriptions of the new
investments made:
· Azarc
(unquoted) -
Cross‑border
customs automation software provider
· CitySwift
(unquoted) - Passenger transport
data and scheduling software provider
· Ozone API
(unquoted) - Open banking software
developer
· SciLeads
(unquoted) - Life Sciences data and
lead generation provider
Following the period end, a total of
£2.1mn was invested as follows:
- follow-on investment of £0.2mn into
Rockfish, a chain of fish restaurants, which is in our unquoted
portfolio
- follow-on investment of £0.2mn into
Yappy, a supplier of customisable pet products, which is in our
unquoted portfolio
- follow-on investment of £0.5mn into
Counting, a banking and software provider for small businesses,
which is in our unquoted portfolio
- new unquoted investment of £1.2mn
into OnSecurity Technology, a penetration testing
provider
Realisations
During the period, in the unquoted
portfolio, Funding Xchange, a SME lending marketplace, was acquired
resulting in a gross money multiple of 0.1x original cost and
Armstrong Craven, a recruitment company, went into administration.
The business had experienced very challenging trading conditions
over the past year and its valuation had already been written down
to zero.
In the listed portfolio, Gresham
House was acquired via a recommended cash offer resulting in a
gross money multiple of 3.9x original cost. The Manager also
continued to take profits from partial sales of the Company's
holding of Cerillion plc resulting in proceeds of £4.1mn, and a
gross money multiple of 21.0x original cost.
Fundraising
I am pleased to report that, shortly
after the period end, the Company successfully raised £25.0mn
(before costs) through an offer for subscription which became fully
subscribed in April 2024. The Directors are pleased to welcome the
800 new shareholders who invested during the offer period and are
appreciative of the continued support of 556 pre-existing
shareholders.
The Board will consider whether to
raise new funds in the 2024/25 tax year. This will be determined by
the Company's cashflow and its anticipated requirements to fund new
and follow-on investments over the next two to three years. The
Board appreciates that shareholders would like plenty of notice of
its fundraising intentions and will ensure that shareholders are
informed of any such fundraising at the earliest practical
time.
Consumer Duty
The FCA's Consumer Duty came into
force on 31 July 2023 and, in summary, requires firms to which this
applies to act to deliver good outcomes for their retail customers.
The Consumer Duty regulations apply to the regulated and ancillary
activities of all FCA authorised firms under the Financial Services
and Markets Act 2000, the Payment Services Regulations 2017 and the
Electronic Money Regulations 2011. The Company is not a FCA
authorised firm and accordingly does not fall within scope of these
regulations. However, the Company's Manager, Gresham House Asset
Management Ltd, being an FCA authorised firm, is covered by the
regulations and the Board is cognisant of the Manager's obligations
to comply with the Consumer Duty. The Board receives regular
updates from the Manager on the delivery of its obligations under
the Consumer Duty and is satisfied that the Manager is complying
with all appropriate regulation.
VCT
Regulation - Financial Health Test
Since the various VCT rule changes
in both 2015 and 2018, VCT qualifying investments have become
focussed on smaller, younger companies. As a result, when the
Manager makes a new investment, they expect to make further
follow-on investments as the investee company progresses and where
the business case for the investment is justified. These follow-on
investments are subject to the same VCT compliance rules as new
deals and both rely on certain criteria being met, including the
Financial Health Test.
The Financial Health Test is not
something new and was primarily introduced as an anti-abuse
regulation. However, following amendment to HMRC's guidance, there
has been an effective tightening of the interpretation the
Financial Health Test. This is resulting in the restriction of
potential follow-on VCT investment to support certain portfolio
companies.
This has the potential to negatively
impact shareholders' returns as a result of portfolio companies
going into administration when they might otherwise have gone on to
be successful. Furthermore, as this is an industry wide issue, this
measure increases the uncertainties small companies face at a
particularly difficult time and may well result in unnecessary job
losses and hardship to employees and their families and has the
potential to reduce the overall tax efficiency of the VCT scheme as
a whole.
In December 2023, the Venture
Capital Trust Association ("VCTA") held a meeting with government
officials to discuss the recent difficulties with the application
of the new guidance. The meeting was successful with the government
officials acknowledging the difficulties. They clarified that going
forward, while the 50% rule (i.e. amount of raised capital
converted to retained losses) will remain the first line of
assessment of financial health, businesses will be given the
opportunity to explain why they should be recognised as financially
healthy even if they do not meet this rule.
The Board continues to monitor
developments in this area carefully and supports the
representations being made by the Association of Investment
Companies ("AIC") and the VCTA to HMRC and HM Treasury.
Outlook
The Board expects that elevated
macroeconomic and global and domestic political uncertainty,
including anaemic UK economic growth and upcoming elections in the
UK in July and US in November, will continue to drive market
volatility over the coming months. Global investors remain
particularly sensitive to new inflation data and shifting central
bank commentary on interest rates, while conflicts in the Ukraine
and the Middle East threaten regional stability.
Against this, the Company's
portfolio remains highly diversified and is largely positioned in
sectors which the Manager expects to provide long-term growth
potential. We remain committed to investing through the economic
cycle as experience suggests that this can produce superior returns
over the longer term. This can also provide an opportunity for the
Company to make high quality investments and build strategic stakes
in businesses with great potential at attractive prices. This
applies to both new investments and follow-on investments in the
portfolio. The Manager continues to see a good pipeline of
potential investments and the Board is confident that the Company
remains suitably resourced to support investment into new and
existing portfolio companies.
Sarah Fromson
Chair
10 June 2024
Investments in the
period
Company
|
Location
|
Sector
|
Activity
|
Book
cost £'000
|
Unquoted investments
New
|
Ozone Financial Technology
Ltd
|
London
|
Technology
|
Open banking infrastructure
provider
|
1,847
|
Huddl Mobility Ltd (trading as
CitySwift)
|
Ireland
|
Technology
|
SaaS product for bus operators and
local authorities to aggregate, cleanse and access insight from
data from across their bus networks
|
938
|
SciLeads Ltd
|
London
|
Technology
|
A data‑intelligence platform that enables
companies operating within Life Science verticals to identify,
track and convert potential customers
|
915
|
Azarc.io Inc
|
London
|
Technology
|
Automating customs
declarations
|
652
|
Follow-on
|
Patchworks Integration
Ltd
|
London
|
Technology
|
Leading integration platform for
fast‑growing retail
and ecommerce businesses
|
910
|
Metrion Biosciences Ltd
|
Cambridgeshire
|
Healthcare &
education
|
Ion channel drug discovery and
safety assessment services provider
|
548
|
Focal Point Positioning
Ltd
|
Cambridgeshire
|
Technology
|
A research and development focused
technology business focusing on global navigation and satellite
systems
|
227
|
Orri Ltd
|
London
|
Healthcare &
education
|
Provider of intensive day care
treatments for eating disorders
|
114
|
Total unquoted investments
|
6,151
|
AIM-traded investments
|
Follow-on
|
Eden Research plc
|
Oxfordshire
|
Business services
|
Developer of biological fungicides
and bio equivalents
|
895
|
PCI‑PAL plc
|
London
|
Technology
|
Secure payment services
provider
|
239
|
Total AIM-traded investments
|
1,134
|
Total investments in the period#
|
7,285
|
# Includes unquoted and AIM
investments only.
Company
|
|
First investment
date
|
Original book
cost# £'000
|
Proceeds‡
£'000
|
Overall multiple return
(x)
|
IRR (%)
|
|
Unquoted realisations
|
Funding Xchange Ltd
|
Full trade sale
|
Nov
19
|
795
|
50
|
0.1
|
0.0
|
|
Armstrong Craven Ltd
|
Written off
|
Jun
13
|
664
|
-
|
1.1*
|
1.6
|
|
Total unquoted realisations
|
|
|
1,459
|
50
|
|
|
|
AIM-traded realisations
|
|
Cerillion plc
|
Market sale
|
Jul
15
|
196
|
4,127
|
21.0
|
44.3
|
|
Gresham House plc
|
Takeover
|
Nov
14
|
137
|
530
|
3.9
|
15.9
|
|
Total AIM - traded realisations
|
|
|
333
|
4,657
|
|
|
|
Total realisations in the period**
|
|
|
1,792
|
4,707
|
|
|
|
Realisations in the period
Liquidation proceeds of £114k were
received during the period from InterQuest Group plc, which was
written off in September 2023.
# Residual book cost at realisation date.
‡ Proceeds at time of realisation including
interest.
* Includes interest/dividends
received, loan note redemptions and partial realisations accounted
for in prior periods.
** Includes unquoted and AIM
investments only.
Responsibility statement of the Directors in respect of the
half-yearly report
Half-yearly report
The important events that have
occurred during the period under review, the key factors
influencing the
financial statements and the
principal uncertainties for the remaining six months of the
financial year are set out in the Chair's statement and the
Strategic report.
The principal risks facing the
Company are unchanged since the date of the Company's Annual Report
for the financial year ended 30 September 2023 and continue to
be as set out in that Report on pages 22 and 23.
Risks faced by the Company include
but are not limited to; loss of approval as a Venture Capital
Trust, legislative risk, investment performance risk, risk of
economic, political and other external factors, regulatory and
compliance risk and operational risk. The Board considers the
conflicts in Ukraine and the Middle East to be factors which
permeate these risks, and their impacts for the remaining six
months of the year continue to be kept under review.
Responsibility statement
Each director confirms that to the
best of their knowledge:
- the condensed set of financial
statements has been prepared in accordance with FRS 104 Interim
Financial Reporting Standards and gives a true and fair view of the
assets, liabilities, financial position and profit or loss of the
Company.
- This half-yearly report includes a
fair review of the information required by:
a) DTR 4.2.7R of the Disclosure Guidance and
Transparency Rules, being an indication of important events that
have occurred during the first six months of the financial
year and their impact on the condensed set of financial statements;
and a description of the principal risks and uncertainties for the
remaining six months of the year; and
b) DTR 4.2.8R of the Disclosure Guidance and
Transparency Rules, being related party transactions that have
taken place in the first six months of the current financial year
and that have materially affected the financial position or
performance of the Company during that period; and any changes in
the related party transactions described in the last annual report
that could do so.
The half-yearly report was approved
by the Board of Directors on 10 June 2024 and was signed on its
behalf by Ms Sarah Fromson, Chair.
Sarah Fromson
Chair
10 June 2024
Condensed income statement
For
the six months to 31 March 2024 (Unaudited)
|
|
Six months to
31 March 2024
|
Six
months to
31 March 2023
|
Year
to
30 September 2023
|
|
Notes
|
Revenue
£'000
|
Capital
£'000
|
Total
£'000
|
Revenue
£'000
|
Capital
£'000
|
Total
£'000
|
Revenue
£'000
|
Capital
£'000
|
Total
£'000
|
|
|
|
|
|
|
|
|
|
|
|
Gains/(losses) on
investments
|
5
|
-
|
8,029
|
8,029
|
-
|
(2,132)
|
(2,132)
|
-
|
(4,284)
|
(4,284)
|
Income
|
|
2,100
|
-
|
2,100
|
1,201
|
-
|
1,201
|
3,082
|
-
|
3,082
|
Investment management fee
|
|
(593)
|
(1,779)
|
(2,372)
|
(620)
|
(1,860)
|
(2,480)
|
(1,252)
|
(3,758)
|
(5,010)
|
Other expenses
|
|
(387)
|
-
|
(387)
|
(357)
|
-
|
(357)
|
(700)
|
-
|
(700)
|
Profit /(loss) before taxation
|
|
1,120
|
6,250
|
7,370
|
224
|
(3,992)
|
(3,768)
|
1,130
|
(8,042)
|
(6,912)
|
Taxation
|
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Profit/(loss) for the period, being total comprehensive income
for the period
|
|
1,120
|
6,250
|
7,370
|
224
|
(3.992)
|
(3,768)
|
1,130
|
(8,042)
|
(6,912)
|
Return per ordinary share:
|
|
|
|
|
|
|
|
|
|
|
Basic and Diluted
|
2
|
0.31p
|
1.71p
|
2.02p
|
0.07p
|
(1.21p)
|
(1.14p)
|
0.33p
|
(2.32p)
|
(1.99p)
|
All items in the above statement
derive from continuing operations.
There are no recognised gains and
losses other than those disclosed in the Income
Statement.
The revenue column of the Income
Statement includes all income and expenses. The capital column
accounts for the realised and unrealised profit or loss on
investments and the proportion of the management fee charged to
capital.
The total column of this statement
is the unaudited Statement of Total Comprehensive Income of the
Company prepared in accordance with the Financial Reporting
Standard ("FRS"). The supplementary revenue return and capital
return columns are prepared in accordance with the Statement of
Recommended Practice issued by the Association of Investment
Companies ("AIC SORP").
Condensed statement of changes in equity
For the six months to 31 March 2024
(Unaudited)
|
|
Non-distributable
reserves
|
|
Distributable
reserves
|
|
|
Called-up share
capital
£'000
|
Share
premium
£'000
|
Revaluation
reserve
£'000
|
|
Capital
reserve
£'000
|
Revenue
reserve
£'000
|
Total
£'000
|
At
1 October 2023
|
39,628
|
-
|
23,062
|
|
144,092
|
2,877
|
209,659
|
Profit after taxation
|
-
|
-
|
5,700
|
|
550
|
1,120
|
7,370
|
Net proceeds of share issues, share
buybacks & sale of shares from treasury
|
1,347
|
6,666
|
-
|
|
(1, 627)
|
-
|
6,386
|
Dividends paid
|
-
|
-
|
-
|
|
(7,965)
|
(371)
|
(8,336)
|
Share premium cancellation
costs
|
-
|
-
|
-
|
|
(4)
|
-
|
(4)
|
At
31 March 2024
|
40,975
|
6,666
|
28,762
|
|
135,046
|
3,626
|
215,075
|
|
|
|
|
|
|
|
|
|
|
For
the six months to 31 March 2023 (Unaudited)
|
|
Non-distributable reserves
|
|
Distributable reserves
|
|
|
Called-up
share capital
£'000
|
Share
premium
£'000
|
Revaluation
reserve
£'000
|
|
Capital
reserve
£'000
|
Revenue
reserve
£'000
|
Total
£'000
|
At
1 October 2022
|
35,789
|
106,099
|
18,834
|
|
49,142
|
3,122
|
212,986
|
(Loss)/profit after
taxation
|
-
|
-
|
(3,433)
|
|
(559)
|
224
|
(3,768)
|
Net proceeds of share issues, share
buybacks & sale of shares from treasury
|
1,933
|
10,718
|
-
|
|
(771)
|
-
|
11,880
|
Dividends paid
|
-
|
-
|
-
|
|
(9,116)
|
(1,013)
|
(10,129)
|
At
31 March 2023
|
37,722
|
116,817
|
15,401
|
|
38,696
|
2,333
|
210,969
|
|
|
|
|
|
|
|
|
|
|
For
the year ended 30 September 2023 (Audited)
|
Non-distributable
reserves
|
Distributable reserves
|
Total
£'000
|
Called-up
share capital
£'000
|
Share
premium
£'000
|
Revaluation
reserve
£'000
|
Capital
reserve
£'000
|
Revenue
reserve
£'000
|
At
1 October 2022
|
35,789
|
106,099
|
18,834
|
49,142
|
3,122
|
212,986
|
Profit/(loss) after
taxation
|
-
|
-
|
4,228
|
(12,270)
|
1,130
|
(6,912)
|
Net proceeds of share issues, share
buybacks & sale of shares from treasury
|
3,839
|
20,452
|
-
|
(2,413)
|
-
|
21,878
|
Dividends paid
|
-
|
-
|
-
|
(16,901)
|
(1,375)
|
(18,276)
|
Cancellation of share
premium
|
-
|
(126,551)
|
-
|
126,551
|
-
|
-
|
Share premium cancellation
costs
|
-
|
-
|
-
|
(17)
|
-
|
(17)
|
At
30 September 2023
|
39,628
|
-
|
23,062
|
144,092
|
2,877
|
209,659
|
|
|
|
|
|
|
|
Condensed balance sheet
As at 31 March 2024
(Unaudited)
|
Notes
|
As at
31 March
2024
£'000
|
As at
31 March
2023
£'000
|
As at
30 September 2023
£'000
|
|
|
|
|
|
|
|
Fixed assets
|
|
|
|
|
|
Unquoted investments
|
5
|
54,585
|
48,545
|
50,506
|
|
Traded on AIM
|
5
|
81,557
|
77,655
|
78,973
|
|
Collective investment
vehicles
|
5
|
79,077
|
69,933
|
80,764
|
|
Investments
|
5
|
215,219
|
196,133
|
210,243
|
|
|
|
|
|
|
|
Current assets
|
|
|
|
|
|
Debtors
|
|
565
|
1,477
|
235
|
|
Cash at bank and on
deposit
|
|
674
|
14,803
|
670
|
|
|
|
1,239
|
16,280
|
905
|
|
Creditors (amounts falling
due within one year)
|
|
(1,383)
|
(1,444)
|
(1,489)
|
|
|
|
|
|
|
|
Net
current (liabilities)/assets
|
|
(144)
|
14,836
|
(584)
|
|
|
|
|
|
|
|
Net
assets
|
|
215,075
|
210,969
|
209,659
|
|
|
|
|
|
|
|
Capital and reserves
|
|
|
|
|
|
Called-up share capital
|
3
|
40,975
|
37,722
|
39,628
|
|
Share premium
|
|
6,666
|
116,817
|
-
|
|
Capital reserve
|
|
135,046
|
38,696
|
144,092
|
|
Revaluation reserve
|
5
|
28,762
|
15,401
|
23,062
|
|
Revenue reserve
|
|
3,626
|
2,333
|
2,877
|
|
Equity shareholders' funds
|
|
215,075
|
210,969
|
209,659
|
|
|
|
|
|
|
|
Net
asset value per share
|
|
57.7p
|
61.0p
|
57.9p
|
|
Number of ordinary shares in
circulation
|
|
372,888,416
|
345,640,159
|
362,253,166
|
|
|
|
|
|
|
|
|
Condensed statement of cash flows
For the six months to 31 March 2024
(Unaudited)
|
Six months to
31 March
2024
£'000
|
Six months
to
31 March
2023
£'000
|
Year
to
30 September
2023
£'000
|
|
|
|
|
Net cash outflow from operating
activities
|
(1,799)
|
(2,035)
|
(3,588)
|
Net cash inflow/(outflow) from
investing activities
|
3,775
|
(21,534)
|
(35,966)
|
Net cash inflow/(outflow) before
financing activities
|
1,976
|
(23,569)
|
(39,554)
|
Net cash (outflow)/inflow from
financing activities
|
(1,972)
|
1,750
|
3,602
|
|
|
|
|
Increase/(decrease) in cash
|
4
|
(21,819)
|
(35,952)
|
|
|
|
|
Reconciliation of new cash flow to movement in net
cash
|
|
|
|
Increase/(decrease) in
cash
|
4
|
(21,819)
|
(35,952)
|
Opening cash at bank and on
deposit
|
670
|
36,622
|
36,622
|
|
|
|
|
Closing cash at bank and on deposit
|
674
|
14,803
|
670
|
|
|
|
|
Reconciliation of profit/(loss) before
taxation
to
net cash outflow from operating activities
|
|
|
|
Profit/(loss) before
taxation
|
7,370
|
(3,768)
|
(6,912)
|
(Gains)/losses on
investments
|
(8,029)
|
2,132
|
4,284
|
Changes in working capital and other
non-cash items
|
(1,140)
|
(399)
|
(960)
|
|
|
|
|
Net
cash outflow from operating activities
|
(1,799)
|
(2,035)
|
(3,588)
|
Notes to the financial statements
For
the six months to 31 March 2024 (Unaudited)
1.
Basis of preparation
The condensed financial statements
for the six months to 31 March 2024 comprise the unaudited
financial statements set out on pages 13 to 16 together with the
related notes on pages 17 to 20. The Company applies FRS 102 and
the AIC SORP for its annual financial statements. The condensed
financial statements for the six months to 31 March 2024 have
therefore been prepared in accordance with FRS 104 'Interim
Financial Reporting' and the principles of the AIC SORP. They have
also been prepared on a going concern basis. The financial
statements have been prepared on the same basis as the accounting
policies set out in the Company's Annual Report and Financial
Statements for the year ended 30 September 2023.
The financial information contained
in this half‑yearly
report does not constitute statutory accounts as defined in
sections 434 - 436 of the Companies Act 2006. The
half‑yearly report
for the six months ended 31 March 2024 and for the six months
ended 31 March 2023 have been neither audited nor reviewed by
the Company's Auditor. The information for the year to
30 September 2023 has been extracted from the latest published
audited financial statements, which have been filed with the
Registrar of Companies. The report of the Auditor for the audited
financial statements for the year to 30 September 2023 was:
(i) unqualified; (ii) did not include a reference to any matters to
which the Auditor drew attention by way of emphasis without
qualifying their report; and (iii) did not contain a statement
under section 498 (2) or (3) of the Companies Act 2006. No
statutory accounts in respect of any period after 30 September
2023 have been reported on by the Company's Auditor or delivered to
the Registrar of Companies.
The Company's half yearly report has been made available on the Company's
website (www.baronsmeadvcts.co.uk)
and sent to shareholders where requested.
2. Performance and shareholder
returns
Return per share is based on a
weighted average of 365,445,232 ordinary shares in issue
(31 March 2023 - 330,678,751 ordinary shares;
30 September 2023 - 346,626,977 ordinary shares).
Earnings for the first six months to
31 March 2024 should not be taken as a guide to the results of
the full financial year to 30 September 2024.
3. Called-up share capital
The below table details the movement
in called-up share capital during the period.
Allotted, called-up and fully paid:
Ordinary shares
|
£'000
|
396,279,533 ordinary shares of 10p
each listed at 30 September 2023
|
39,628
|
13,468,470 ordinary shares of 10p
each issued during the period
|
1,347
|
409,748,003 ordinary shares of 10p each listed at 31 March
2024
|
40,975
|
34,026,367 ordinary shares of 10p
each held in treasury at 30 September 2023
|
(3,403)
|
2,833,220 ordinary shares of 10p
each repurchased during the period and held in treasury
|
(283)
|
36,859,587 ordinary shares of 10p each held in treasury at 31
March 2024
|
(3,686)
|
372,888,416 ordinary shares of 10p each in circulation* at 31
March 2024
|
37,289
|
* Carrying one vote each.
|
|
During the six months to 31 March 2024 the Company issued
13,468,470 shares at net proceeds of £7,957,000 (after costs).
During the same period, the Company purchased 2,833,220 shares to
be held in treasury at a cost of £1,571,000 (including costs). The
Company sold no shares from treasury. At 31 March 2024, the Company
held 36,859,587 ordinary shares in treasury. Shares may be sold out
of treasury below Net Asset Value as long as the discount at issue
is narrower than the average discount at which the shares were
bought into treasury.
Excluding treasury shares, there
were 372,888,416 ordinary shares in circulation at 31 March 2024
(31 March 2023 - 345,640,159 ordinary shares; 30 September 2023 -
362,253,166 ordinary shares).
4. Dividends
The final dividend for the year
ended 30 September 2023 of 2.25p per share (2.15p capital, 0.10p
revenue) was paid on 8 March 2024 to shareholders on the
register on 9 February 2024. The ex-dividend date was 8 February
2024.
During the year to 30 September
2023, the Company paid an interim dividend on 8 September 2023 of
2.25p per share (2.15p capital, 0.10p revenue).
An interim dividend of 1.75p per
share has been declared for the year to 30 September 2024 and is
payable on 9 September 2024 to shareholders on the register as
of 9 August 2024. The ex-dividend date is 8 August
2024.
5. Investments
All investments are initially
recognised and subsequently measured at fair value. Changes in fair
value are recognised in the Income Statement.
The methods of fair value
measurement are classified into a hierarchy based on reliability of
the information used to determine the valuation.
- Level 1 -
Fair value is measured based on quoted prices in an active
market.
- Level 2 -
Fair value is measured based on directly observable current market
prices or indirectly being derived from market prices.
- Level 3 -
Fair value is measured using a valuation technique that is not
based on data from an observable market.
The valuation of unquoted
investments contained within level 3 of the Fair Value hierarchy
involves key assumptions dependent upon the valuation methodology
used. The primary methodologies applied are:
· Cost
of recent investment.
· Earnings multiple.
· Offer
less 10 per cent.
The earnings multiple approach
involves more subjective inputs than the cost of recent investment
and offer approaches and therefore presents a greater risk of over
or under estimation. Key assumptions for the earnings multiple
approach are the selection of comparable companies and the use of
either historic or forecast revenue or earnings, as considered most
appropriate. Other assumptions include the appropriateness of the
discount magnitude applied for reduced liquidity and other
qualitative factors. These assumptions are described in more detail
in note 2.3 in the Company's Report and Financial Statements for
the year to 30 September 2023. The techniques used in the valuation
of unquoted investments have not changed materially since the date
of that report.
|
Level 1
|
Level 2
|
Level 3
|
|
|
Traded
on AIM
£'000
|
Collective
investment
vehicles
£'000
|
Unquoted
£'000
|
Total
£'000
|
Opening book cost
|
64,431
|
65,537
|
57,213
|
187,181
|
Opening unrealised
appreciation/(depreciation)
|
14,542
|
15,227
|
(6,707)
|
23,062
|
Opening fair value
|
78,973
|
80,764
|
50,506
|
210,243
|
Movements in the year:
|
|
|
|
|
Transfer between levels
|
(1,650)
|
-
|
1,650
|
-
|
Purchases at cost
|
1,134
|
11,604
|
6,151
|
18,889
|
Sale - proceeds
|
(4,657)
|
(17,120)
|
(165)
|
(21,942)
|
- realised gains on
sales
|
759
|
-
|
164
|
923
|
Unrealised gains/(losses) realised
during the year
|
3,535
|
-
|
(2,129)
|
1,406
|
Increase/(decrease) in unrealised
appreciation
|
3,463
|
3,829
|
(1,592)
|
5,700
|
Closing fair value
|
81,557
|
79,077
|
54,585
|
215,219
|
Closing book cost
|
63,552
|
60,021
|
62,884
|
186,457
|
Closing unrealised
appreciation/(depreciation)
|
18,005
|
19,056
|
(8,299)
|
28,762
|
Closing fair value
|
81,557
|
79,077
|
54,585
|
215,219
|
Equity shares
|
81,557
|
-
|
23,478
|
105,035
|
Preference shares
|
-
|
-
|
20,997
|
20,997
|
Loan notes
|
-
|
-
|
10,110
|
10,110
|
Collective investment
vehicles
|
-
|
79,077
|
-
|
79,077
|
Closing fair value
|
81,557
|
79,077
|
54,585
|
215,219
|
6. Other required disclosures
6.1 Segmental reporting
The Company has one reportable
segment being investing in primarily a portfolio of UK growth
businesses, whether unquoted, traded on AIM or collective
investment vehicles.
6.2 Principal risks and uncertainties
The Company's assets consist of
equity and fixed interest investments, shares in collective
investment schemes, cash and liquid resources. Its principal risks
are therefore market risk, price risk, credit risk and liquidity
risk. Other risks faced by the Company include loss of approval as
a Venture Capital Trust, legislative, investment performance,
economic, political and other external factors, regulatory and
compliance and operational risks. These risks, and the way in which
they are managed, are described in more detail in the principal
risks and uncertainties table within the Strategic report section
in the Company's Annual Report and Financial Statements for the
year ended 30 September 2023. The Board continues to regularly review the risk environment in which
the Company operates.
6.3 Related parties
Gresham House Asset Management Ltd
(the "Manager") manages the investments of the Company. The Manager
also provides or procures the provision of secretarial, accounting,
administrative and custodian services to the Company. Under the
management agreement, the Manager receives a fee of 2.5 per cent.
per annum of the net assets of the Company up to and including
£209,658,860 (being the total net assets of the Company as at 30
September 2023) and 2.0 per cent. per annum of the amount by which
the net assets of the Company exceed £209,658,860. This is
described in more detail under the heading 'The management
agreement' within the Strategic Report in the Company's Annual
Report and Financial Statements for the year ended 30 September
2023. During the period the Company has incurred management fees of
£2,372,000 (31 March 2023 - £2,480,000; 30 September 2023 -
£5,010,000) and secretarial and accounting fees of £89,000 (31
March 2023 - £80,000; 30 September 2023 - £167,000) payable to the
Manager. No performance fee has been accrued at 31 March 2024 (31
March 2023 - £nil; 30 September 2023 - £nil). This is described in
more detail under the heading 'Performance fees' within the
Strategic Report in the Company's Annual Report and Financial
Statements for the year to 30 September 2023.
Under the terms of an Offer for
Subscription, launched on 4 December 2023, the Manager was entitled
to fees of 4.50% of the investment amount received from investors.
This amount totalled £693,000, including the amounts allotted in
April 2024, out of which all the costs associated with the
allotments were met.
6.4 Going concern
After making enquiries, and bearing
in mind the nature of the Company's business and assets, the
Directors consider that the Company has adequate resources to
continue in operational existence for the foreseeable future. In
arriving at this conclusion, the Directors have considered the
Company's cash balances, the liquidity of the Company's investments
and the absence of any gearing. The Directors are therefore also
satisfied that the Company has adequate financial resources to
continue in operation for at least the next 12 months and that,
accordingly, it is appropriate to adopt the going concern basis in
preparing the financial statements.
6.5 Post balance sheet events
The following events occurred
between the balance sheet date and the signing of these financial
statements:
- The 30 April 2024 NAV of 58.6p was
announced on 7 May 2024 and the 31 May 2024 NAV of 59.8p was
announced on 6 June 2024. At the date of publishing this
report, the Board is unaware of any matter that will have caused
the NAV per share to have changed significantly since the latest
NAV.
- Purchased 0.6mn Ordinary Shares of
10.0p on 2 April 2024 at a price of 55.2p per share to be held in
Treasury.
- Purchased 1.4mn Ordinary Shares of
10.0p on 24 May 2024 at a price of 55.6p per share to be held in
Treasury.
- 27.7mn shares were issued on 3
April 2024 at allotment prices between 59.7p and 62.6p under the
current Offer.
- One new investment, into
OnSecurity Technology, completed in June 2024 totalling
£1.2mn.
- Three follow-on investments, into
Yappy, Rockfish and Counting, completed between April to May 2024,
totalling £1.0mn.
- Partial realisations in Cerillion
were made in May 2024, realising proceeds of £1.8mn and making a
return of 21.0x cost.
- Realised Gama Aviation in May
2024, receiving proceeds of £0.6mn and making a return of 0.6x
cost.
Directors
Sarah Fromson (Chair)†
Malcolm Groat*
Graham McDonald
Tim
Farazmand#
Secretary
Gresham House Asset Management
Ltd
Registered Office
5 New Street Square
London EC4A 3TW
Investment Manager
Gresham House Asset Management
Ltd
5 New Street Square
London EC4A 3TW
Tel: 020 7382 0999
Registered Number
04115341
Registrars and Transfer Office
The City Partnership (UK)
Ltd
The Mending Rooms
Park Valley Mills
Meltham Road
Huddersfeld HD4 7BH
Tel: 01484 240 910
|
Brokers
Panmure Gordon &
Co‡
40 Gracechurch Street
London EC3V 0BT
Tel: 020 7886 2500
Auditor
BDO LLP
55 Baker Street
London W1U 7EU
Solicitors
Howard Kennedy LLP
1 London Bridge
London SE1 9BG
VCT
Status Adviser
PricewaterhouseCoopers
LLP
1 Embankment Place
London WC2N 6RH
Website
www.baronsmeadvcts.co.uk
|
Corporate information
† Chair of the Nomination
Committee.
* Senior Independent Director and Chair of the Audit & Risk
Committee.
# Chair of the Management
Engagement and Remuneration Committee.
‡ Merger between Liberum
and Panmure Gordon completed May 2024.
LEI: 2138008D3WUMF6TW8C28